DYNAMIC WEALTH RESEARCH
  • Stock Market
  • Hard Assets
  • Clean Tech
  • Tech
  • Crypto
  • Cannabis
  • Psychedelics
  • About
    • Contact
  •  
  •  
  •  

Psychedelic Stocks

 Psychedelic Stocks Home

An Investing Roadmap For The Mental Health Crisis

A $225 billion treatment market is badly in need of new therapies. Here is the roadmap for investors to capitalize on this opportunity.

09/18/2020 Jeff Nielson

Functional Mushrooms: The Psychedelics Stepping Stone

Functional mushrooms are a large-and-growing health supplements market with synergies to psychedelics operations.

09/17/2020 PSW Editor

Champignon Provides Update on Disclosure Review

Champignon Brands continues to work with the BC Secutiries Commission to complete its disclosure review.

09/16/2020 PSW Editor

Mydecine Innovations Group, Inc. to Create Special Committee for the Spin Out of US Related Assets

Mydecine is planning to spin out its U.S. legacy cannabis assets.

09/15/2020 PSW Editor

Compass Pathways Raising Up To $107.2 million For IPO, Valuation $500+ Million

Compass Pathways has set the terms for its IPO, targeting a valuation at or about $544.1 million.

09/15/2020 PSW Editor

Is Psilocybin More Revolutionary Than Spravato for Depression?

Spravato has not been the "game-changer" for treating depression that it was touted as being. The market remains wide open for psilocybin (and other psychedelics).

09/14/2020 Jeff Nielson

Havn Life Sciences Granted Section 56 Exemption to Begin Scientific Work With Psilocybin

HAVN Life Science's Health Canada exemption will permit it to conduct psilocybin-based research.

09/10/2020 PSW Editor

Psychedelics Company Havn Life Announces Commencement of Public Trading on the CSE

Havn Life Sciences commences trading on the CSE under the ticker symbol "HAVN".

09/10/2020 PSW Editor

ATAI Positioned As Kingmaker In Psychedelics Space

ATAI Life Sciences is looking more and more like the driving force in the psychedelic drug industry.

09/09/2020 Jeff Nielson

Aion Therapeutic Files Five Patents with the United States Patent and Trademark Office

Aion Therapeutic Inc. has filed several plant-based patents with the USPTO.

09/04/2020 PSW Editor

Havn Life Sciences Inc.: Havn Life Sciences Announces Filing of Final Prospectus and Conditional Approval for CSE Listing

Another private player in the psychedelics industry moves to go public. Prospectus available on SEDAR.

09/03/2020 PSW Editor

Numinus Announces Filing Final Short Form Prospectus for Offering of up to $4,000,000

Numinus seeks to raise CAD$4.0 million at an offering price of CAD$0.25 per unit.

09/03/2020 PSW Editor
  • Previous
  • 1
  • ...
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • ...
  • 72
  • Next

Exclusives

Responsive image
Visible Gold At Depth For Rua Gold As Momentum Builds

New drill results from Rua Gold's Reefton Goldfield Project include a high-grade gold intercept with visible gold in the core sample.


The Silver Short Squeeze: A Historic Market Battle in the Making

Gold stocks’ winter rally 2024

Warren Buffett's Berkshire Hathaway Sells Apple Stock, Boosts Cash Pile to Record

The stock market gives this candidate a 70% chance to be the next U.S. president

SHARE DYNAMIC WEALTH RESEARCH

Our Mission

Learn More


  • About
  • Contact

Contact Us


info@dynamicwealthresearch.org
Direct To Investor Media LLC
100 Wilshire Blvd, Suite 700
Santa Monica, CA 90401

Subscribe to Newsletter

Stay informed on new causes and upcoming organization updates. Don't miss things!

By providing your e-mail, you are consenting to receive press releases and other information concerning Psychedelic Stock Watch and its affiliates and partners. You may withdraw your consent at any time.

UNSUBSCRIBE
© 2016 - 2025 DYNAMIC WEALTH RESEARCH, Privacy Policy, Disclaimer
powered by structure cms™